Overview

Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer

Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
This Phase II study is to determine the efficacy of split-course irradiation with concurrent chemotherapy in locally advanced none-small cell lung cancer patients.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Docetaxel
Nedaplatin